Tags | Domains | Searches | Statistics | Options | Advanced Search
|
Tags | Domains | Searches | Statistics | Options | Advanced Search |
PharmaGazette - Feb 8, 2008
Mylan Inc. (NYSE: MYL) announced that its pharmaceutical division has obtained an order from a judge in Florida finding that Levothyroxine Sodium should not be on the state's negative drug formulary. A drug that is …
Also tagged: news, abt, florida, myl, mylan, levothyroxine sodium
Know More Media - Health Care / Pharmaceutical / Fitness - Feb 8, 2008
Mylan Inc. (NYSE: MYL) announced that its pharmaceutical division has obtained an order from a judge in Florida finding that Levothyroxine Sodium should not be on the state's negative drug formulary. A drug that is …
Know More Media - Health Care / Pharmaceutical / Fitness - Jan 22, 2008
Abbott Laboratories (NYSE:ABT) announced that it has received the fifth indication for its drug Humira. The new indication gives the company U.S. Food and Drug Administration approval to market Humira as a treatment …
Also tagged: abt, drug regulations and approval, humira, psoriasis
PharmaGazette - Jan 22, 2008
Abbott Laboratories (NYSE:ABT) announced that it has received the fifth indication for its drug Humira. The new indication gives the company U.S. Food and Drug Administration approval to market Humira as a treatment …
Also tagged: abt, drug regulations and approval, humira, psoriasis
PharmaGazette - Dec 14, 2007
Abbott Laboratories' (NYSE: ABT ) finds itself at #14 for research and development budget with $1.71 bn EUR and #9 for sales in 2006. Abbott did issue a recall on blood pressure monitors in September and received FDA …
Also tagged: abt, product recall, research and development, niaspan
Know More Media - Health Care / Pharmaceutical / Fitness - Dec 14, 2007
Abbott Laboratories' (NYSE: ABT ) finds itself at #14 for research and development budget with $1.71 bn EUR and #9 for sales in 2006. Abbott did issue a recall on blood pressure monitors in September and received FDA …
Also tagged: abt, product recall, research and development
PharmaGazette - Sep 20, 2007
Users of the following Abbott Labora tories manufactured glucose meters: Precision Xtra™, Optium™, ReliOn® Ultima, Rite Aid® and Kroger® are being warned that dropping the units on a hard surface could cause improper …
Also tagged: diabetes, product recall, glucose meter
Know More Media - Health Care / Pharmaceutical / Fitness - Sep 19, 2007
Users of the following Abbott Labora tories manufactured glucose meters: Precision Xtra™, Optium™, ReliOn® Ultima, Rite Aid® and Kroger® are being warned that dropping the units on a hard surface could cause improper …
Also tagged: diabetes, product recall
PharmaGazette - Jul 10, 2007
Abbott (NYSE: ABT) has simultaneously submitted regulatory applications for its drug product HUMIRA® (adalimumab): a supplemental Biologics License Application (sBLA) with the USFDA seeking approval to market HUMIRA® …
Also tagged: abt, eu, drug regulations and approval, emea, ra, as, humira, jia, jra
PharmaGazette - Jul 10, 2007
Abbott’s investigational treatment, ABT-874, has been found significantly effective in reducing the symptoms of psoriasis in majority of patients treated. Such were the findings from the new Phase II clinical data …
Also tagged: abt, patents and clinical trials, psoriasis